abstract |
An IL-1beta binding molecule is provided, in particular an antibody to human IL-1beta, especially an antibody to human IL-1beta, wherein the CDRs of the heavy and light chains have amino acid sequences as defined, for use. in the treatment of a disease or disorder mediated by IL-1, for example osteoarthritis, osteoporosis, and other inflammatory arthritides. |